Health written question – answered at on 27 February 2006.
To ask the Secretary of State for Health what assessment she has made of the likely impact of the National Institute for Health and Clinical Excellence's recommendations on use of drug treatments for Alzheimer's disease on those in the early stages of the disease.
The National Institute for Health and Clinical Excellence (NICE) has not yet published its final guidance to the national health service following its routine review. Until NICE issues new guidance the original 2001 guidance on anti-dementia drugs remains in force.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.